Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
about
Pump thrombosis-A riddle wrapped in a mystery inside an enigma.Continuous flow left ventricular assist devices: shared care goals of monitoring and treating patientsPredictors of Thromboembolic Events in Patients with Ventricular Assist Device.Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.Management of pump thrombosis in patients with left ventricular assist devices.Coagulopathy in Mechanical Circulatory Support: A Fine Balance.Using medical imaging for the detection of adverse events ("incidents") during the utilization of left ventricular assist devices in adult patients with advanced heart failure.Current status of the implantable LVAD.Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs.New Challenges in the Treatment of Patients With Left Ventricular Support: LVAD Thrombosis.Complications, Risk Factors, and Staffing Patterns for Noncardiac Surgery in Patients with Left Ventricular Assist Devices.Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.Left ventricular assist device hemolysis leading to dysphagia.Neuron-specific enolase correlates to laboratory markers of haemolysis in patients on long-term circulatory support.Percutaneous Transcatheter Therapies for the Management of Left Ventricular Assist Device Complications.Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.Expediting red blood cell transfusions by syringing causes significant hemolysis.Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.Diagnosis of LVAD Thrombus using a High-Avidity Fibrin-Specific 99mTc Probe.Blood cell microparticles as biomarkers of hemostatic abnormalities in patients with implanted cardiac assist devices.[Ventricular long-term support with implantable continuous flow pumps: on the way to a gold standard in the therapy of terminal heart failure].
P2860
Q30423801-4E33B3CF-3DDC-44C7-8E6E-55B212105E8CQ35183409-8CFFBCC4-35EC-4808-8AFC-37B4F6CF749DQ36244709-B584B35D-A15E-40C1-9A50-61E559FDD087Q38261382-3691682A-1943-47CC-B8CB-B807E8F76E09Q38310801-CD4192DF-23FF-4102-A28A-73FE6D6DA34EQ38611535-9744B681-EDDF-4E71-85DE-FCC67C0B529FQ38773019-A1E930EF-E4C0-46AD-8CED-179B2C209E8DQ38857592-D2C3248B-3C85-4461-B15B-F89ABD4E1B18Q38870760-339CA950-16D2-450D-BA09-FEEF03569AB1Q39017690-DC0700A2-0504-4BCC-9644-BA72A1FD5A11Q39036332-98FDE380-3560-4CC9-9D7E-B084379AE6E5Q39190576-787FA551-570F-4CAB-B2F3-4D6E791BE64CQ39852551-0E14F219-A8B0-4684-8617-53314B4CD565Q40546122-E7F19A6F-ED5D-4EDF-8EEB-9AFF705593FBQ41625125-CAC88176-6A70-4679-AFA0-5AE196E1CC08Q42050111-7B3F383A-3C6B-4ABE-8BF4-9335A5D96356Q42772762-F39E5C4C-E4E3-438E-876F-F59CADA7A118Q46841466-32EEFD68-8AA4-4C7E-B8B7-3C553581B431Q47908875-40B3F109-7B98-456C-9EE1-F4A8E1A926DFQ49788040-D474C766-2316-46F4-9743-266B54F3460FQ51159991-7F65A515-48E6-4848-9C9F-E1390DC72E08Q52868288-C6213458-ADAA-486A-ABBB-7F23F950F037
P2860
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@en
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@nl
type
label
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@en
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@nl
prefLabel
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@en
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@nl
P2093
P1476
Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
@en
P2093
Jonathan W Haft
Keith D Aaronson
Matthew A Romano
Palak Shah
Vivek Mehta
P356
10.1016/J.HEALUN.2013.08.021
P577
2013-11-28T00:00:00Z